Approval based on Phase III ETHOS trial which showed a statistically significant reduction in the rate of exacerbations compared with dual-combination therapies AstraZeneca’s Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) has been approved in the...
Glympse Bio Announces $46.7 Million Series B Financing Proceeds Support PMA-Enabling Study of Glympse Technology in NASH Patients CAMBRIDGE, Mass., July 15, 2020 – Glympse Bio (Glympse), a biotechnology company advancing the way diseases are understood, tracked, and...
Iterum Therapeutics Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules DUBLIN, Ireland and CHICAGO, June 30, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused on...
Neurana Pharmaceuticals Announces First Patient Enrolled in CNS Effects Clinical Study SAN DIEGO, Calif., June 8, 2020 – Neurana Pharmaceuticals, Inc., a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced that...
KLAS Rates TigerConnect Among Top Advanced Clinical Communication Platforms KLAS recognizes TigerConnect for its highly customer-centric, very large customer base across inpatient and non-inpatient care settings, delivering nimble development and “most extensive...
Recent Comments